Characterization of [3H]substance P binding sites in human skin

Journal of the European Academy of Dermatology and Venereology

Volumn 12, Issue 1, 1999, Pages 6-10

  Bianchi, Beatrice ^a   Matucci, Rosanna ^a   Danesi, Alessandro ^a   Rossi, Riccardo ^a   Ipponi, Pierluigi ^b   Giannotti, Benvenuto ^a   Johansson, Olle ^c   Cappugi, Pietro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Microbiological Laboratory   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Neurokinins; Neuropeptides; Skin; SP receptors

Indexed keywords

NEUROKININ; NEUROPEPTIDE; SUBSTANCE P; SUBSTANCE P RECEPTOR; TACHYKININ RECEPTOR; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; NEUROKININ A; NEUROKININ A(4 10), TYR(5) TRP(6,8,9) LYS(10); NEUROKININ A(4-10), TYR(5)-TRP(6,8,9)-LYS(10)-; NEUROKININ B; NEUROKININ B, MEPHE(7); NEUROKININ B, MEPHE(7)-; PEPTIDE FRAGMENT; SUBSTANCE P, SAR(9) MET(O2)(11); SUBSTANCE P, SAR(9)-MET(O2)(11)-; TRITIUM;

ARTICLE; BINDING AFFINITY; BINDING SITE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; SKIN DISEASE; AGED; BINDING COMPETITION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; MALE; METABOLISM; MIDDLE AGED; RADIOASSAY; SKIN;

AGED; BINDING, COMPETITIVE; FEMALE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; MALE; MIDDLE AGED; NEUROKININ A; NEUROKININ B; PEPTIDE FRAGMENTS; RADIOLIGAND ASSAY; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RECEPTORS, NEUROKININ-3; SKIN; SUBSTANCE P; TRITIUM;

EID: 0032587386     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(98)00120-2     Document Type: Article

References (25)

1. Maggi CA, Patacchini R, Rovero P, Giachetti A. Tachykinin receptors and tachykinin receptor antagonist. J Auton Pharmacol 1993;13:23-93.
2. Brodin E, Gazelius B, Edvinsson L, Olgart L. Tachykinins in peripheral sensory nerve endings: occurrence and release. In: Sicuteri F, et al., editors. Trends in cluster headache. Amsterdam: Elsevier Science, 1987:209-220.
3. Moskowitz MA, Kuo C, Leeman SE, Jessen ME, Derian CK. Desensitization to substance P-induced vasodilation in vitro is not shared by endogenous tachykinin neurokinin A. J Neurosci 1987;7:2344-2351.
4. Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol 1979;310:175-183.
5. Piotrowsky W, Foreman JC. On the actions of substance P, somatostatin and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin. Naunyn Schmiedebergs Arch Pharmacol 1985;331:364-368.
6. Dalsgaard CI, Jonsson CE, Hökfelt T, Cuello AC. Localization of substance P-immunoreactive nerve fibers in the human digital skin. Experientia 1983;39:1018-1020.
7. Wallengren J, Ekman R, Sundler F. Occurrence and distribution of neuropeptides in human skin. An immunocytochemical and immunochemical study on normal skin and blister fluid from inflamed skin. Acta Dermatol Venereol 1987;67:185-192.
8. Nilsson J, Von Euler AM, Dalsgaard CJ. Stimulation of connective tissue cell growth by substance P and substance K. Nature 1985;315:61-63.
9. Dalsgaard CJ, Hultgårdh-Nilsson A, Haegerstrand A, Nilsson J. Neuropeptides as growth factors. Possible roles in human diseases. Regul Pept 1989;25:1-9.
10. Tanaka T, Danno K, Ikai K, Imamura SJ. Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol 1988;90:399-401.
11. Kemeny L, Von Restoff B. Specific binding and lack of growth-promoting activity of substance P in cultured human keratinocytes. J Invest Dermatol 1994;103:605.
12. Mussap CJ, Geraghty DP, Burcher E. Tachykinin receptors: a radioligand binding perspective. J Neurochem 1993;60:1987-2009.
13. Regoli D, Boudon A, Fauchére JL. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 1994;46:551-599.
14. Pincelli C, Fantini F, Giardino L, et al. Autoradiographic detection of substance P receptors in normal and psoriatic skin. J Invest Dermatol 1993;101:301-304.
15. Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein, utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
16. 3H-Substance P binding to salivary gland membranes. Regulation by guanyl nucleotides and divalent cations. Mol Pharmacol 1983;23:563-569.
17. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for the characterization of ligand-binding systems. Anal Biochem 1980;107:220-239.
18. De Lean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978;235:E97-E102.
19. Dam TV, Quirion R. Pharmacological characterization and autoradiographical localization of substance P receptors in guinea-pig brain. Peptides 1986;7:855-864.
20. 3H] substance P in rat cerebral cortex. Brain Res 1993;601:34-40.
21. Gitter BD, Waters DC, Bruns RF, Mason NR, Nixon JA, Howbert JJ. Species differences in affinities of non-peptide antagonists for substance P receptors. Eur J Pharmacol 1991;197:237-238.
22. Cascieri MA, Liang T. Characterization of the substance P receptor in rat brain cortex membranes and the inhibition of radioligand binding by guanine nucleotides. J Biol Chem 1983;258:5158-5164.
23. MacDonald SG, Boyd ND. Regulation of substance P receptor affinity by guanine nucleotide-binding proteins. J Neurochem 1989;53:264-272.
24. Ahuluwalia A, Giuliani S, Maggi CA. Demonstration of a 'peptide-sensitive' inflammatory response in rat skin. Br J Pharmacol 1995;116:2170-2174.
25. Walsh DT, Weg VB, Williams TJ, Nourshargh S. Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators. Br J Pharmacol 1995;114:1343-1350.